SuperworthEdwards Lifesciences market cap EW
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Oct 23, 2026
- $51.3B
- Highest close in our data
- $80.9B
- Dec 2021
Edwards Lifesciences is worth $51.3B at the close on Oct 23, 2026, at $89.07 a share.
That is up 15% over the last year and down 31% over five years.
Its highest close in our data was $80.9B in Dec 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $51.3B | $44B | $54.3B | +2% |
| 2025 | $50.4B | $40.7B | $50.4B | +13% |
| 2024 | $44.6B | $36.6B | $57.5B | −4% |
| 2023 | $46.2B | $37.5B | $57.2B | +0% |
| 2022 | $46.1B | $42.4B | $77.2B | −43% |
| 2021 | $80.9B | $49.6B | $80.9B | +42% |
| 2020 | $56.9B | $34.8B | $56.9B | +16% |
| 2019 | $48.9B | $31.1B | $51.2B | +56% |
| 2018 | $31.4B | $24.5B | $36.5B | +32% |
| 2017 | $23.9B | $19.2B | $25.2B | +19% |
| 2016 | $20B | $16.1B | $25.7B | +18% |
| 2015 | $17B | $13.4B | $17.8B | +23% |
| 2014 | $13.9B | $7.1B | $14.3B | +92% |
| 2013 | $7.2B | $6.7B | $10.9B | −30% |
| 2012 | $10.3B | $7.9B | $12.6B | +28% |
| 2011 | $8.1B | $7.1B | $10.4B | −13% |
| 2010 | $9.2B | $6.3B | $9.7B | n/a |
Against its peers
Companies in Medical - Devices nearest Edwards Lifesciences' size, closest first, today.
| Company | Market cap |
|---|---|
| EWEdwards Lifesciences | $51.3B |
| BSXBoston Scientific | $66.2B |
| GEHCGE HealthCare Technologies | $32.3B |
| DXCMDexCom | $29.4B |
| SYKStryker | $117.8B |
| MDTMedtronic | $122B |
| ZBHZimmer Biomet | $18.8B |
| ABTAbbott Laboratories | $179.4B |
| Peer median | $66.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Edwards Lifesciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.